Mayne Pharma Group (STU:HG6) Scaled Net Operating Assets : 0.30 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Mayne Pharma Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mayne Pharma Group's operating assets for the quarter that ended in Jun. 2024 was €613.1 Mil. Mayne Pharma Group's operating liabilities for the quarter that ended in Jun. 2024 was €401.1 Mil. Mayne Pharma Group's Total Assets for the quarter that ended in Dec. 2023 was €707.5 Mil. Therefore, Mayne Pharma Group's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.30.

Mayne Pharma Group Scaled Net Operating Assets Historical Data

The historical data trend for Mayne Pharma Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Scaled Net Operating Assets Chart

Mayne Pharma Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.79

0.58

0.63

0.33

0.27

Mayne Pharma Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.63	0.52	0.30	0.34	0.30

Competitive Comparison of Mayne Pharma Group's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mayne Pharma Group's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's Scaled Net Operating Assets falls into.

Mayne Pharma Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mayne Pharma Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2024 )
=	(Operating Assets (A: Jun. 2024 )	-	Operating Liabilities (A: Jun. 2024 ))	/	Total Assets (A: Jun. 2023 )
=	(613.102	-	401.067)	/	772.69
=	0.27

where

	Operating Assets		(A: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	705.187	-	92.085
=	613.102

	Operating Liabilities		(A: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	425.014	-	21.591	-	2.356
=	401.067

Mayne Pharma Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(613.102	-	401.067)	/	707.482
=	0.30

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	705.187	-	92.085
=	613.102

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	425.014	-	21.591	-	2.356
=	401.067

Mayne Pharma Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (STU:HG6) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

MAYNF:USA HG6:Germany MYX:Australia

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

Mayne Pharma Group Headlines

No Headlines